Abacavir (American Health Packaging)


Welcome to the PulseAid listing for the Abacavir drug offered from American Health Packaging. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: American Health Packaging
NON-PROPRIETARY NAME: Abacavir Sulfate
SUBSTANCE NAME: ABACAVIR SULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-01-24
END MARKETING DATE: 0000-00-00


Abacavir HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAbacavir from American Health Packaging
LABELER NAME: American Health Packaging
DEA SCHEDULE:
ACTIVE STRENGTH: 300(mg/1)
START MARKETING DATE: 2013-01-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68084-021_5cdbcf4a-4b9b-5549-e053-2991aa0a6550
PRODUCT NDC: 68084-021
APPLICATION NUMBER: ANDA077844

Other ABACAVIR SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health PackagingAbacavir
Apotex CorpAbacavir Sulfate
Aurobindo Pharma LimitedAbacavir
Avera McKennan HospitalAbacavir Sulfate
Camber Pharmaceuticals, Inc.Abacavir
Major PharmaceuticalsAbacavir Sulfate
Mylan Institutional Inc.Abacavir Sulfate
Mylan Pharmaceuticals Inc.Abacavir Sulfate
REMEDYREPACK INC.Abacavir Sulfate
State of Florida DOH Central PharmacyZIAGEN
Strides Shasun LimitedAbacavir
ViiV Healthcare CompanyZIAGEN